|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J. Biol. Chem., Vol. 281, Issue 28, 18942-18952, July 14, 2006
Chondroitin Sulfate/Dermatan Sulfate Hybrid Chains in the Development of CerebellumSPATIOTEMPORAL REGULATION OF THE EXPRESSION OF CRITICAL DISULFATED DISACCHARIDES BY SPECIFIC SULFOTRANSFERASES*From the Department of Biochemistry, Kobe Pharmaceutical University, Higashinada-ku, Kobe 658-8558, Japan
Received for publication, October 5, 2005 , and in revised form, March 20, 2006.
Chondroitin sulfate/dermatan sulfate (CS/DS) chains regulate the development of the central nervous system in vertebrates. Previously, we demonstrated that CS/DS hybrid chains from embryonic pig brain exhibit neuritogenic and growth factor binding activities, which depended on their IdoUA content defining the DS-like structure. To elucidate the distribution of such functional sugar chains during the development of the brain, in situ hybridization was performed to examine expression of three CS/DS GalNAc 4-O-sulfotransferases, D4ST-1, C4ST-1, and C4ST-2, and a single uronyl 2-O-sulfotransferase (UST) involved in the biosynthesis of DS in addition to CS intermediates. C4ST-1 and C4ST-2 were ubiquitously expressed in the postnatal mouse brain, whereas the expression of D4ST-1 and UST was restricted in the developing cerebellum and culminated at postnatal day 14 as shown by reverse transcriptase-PCR analysis. In situ analysis of the disaccharides of CS/DS in brain sections revealed that the concentration of CS/DS increases 2-fold during development (postnatal day 7 to 7 weeks). The proportions of DS-specific, principal disaccharides, IdoUA-Gal-NAc(4-O-sulfate) (iA) and IdoUA(2-O-sulfate)-GalNAc(4-O-sulfate) (iB), produced by the sequential actions of D4ST-1 and UST, were higher in the CS/DS chains from cerebellum than those from whole brain sections. A dramatic increase (10-fold) in the proportion of iB during development was noteworthy. In contrast, GlcUA/IdoUA(2-O-sulfate)-GalNAc(6-O-sulfate) (D/iD) and GlcUA/IdoUA-GalNAc(4, 6-O-disulfate) (E/iE) decreased to 50 and 30%, respectively, in the developing cerebellum. These results suggest that the IdoUA-containing iA and iB units along with D/iD and E/iE units in the CS/DS hybrid play important roles in the formation of the cerebellar neural network during postnatal brain development.
Chondroitin sulfate (CS)3 and dermatan sulfate (DS) are sulfated glycosaminoglycan (GAG) chains with enormous structural diversity and are covalently attached to various core proteins to form proteoglycans (PGs). PGs show a widespread distribution in extracellular matrices and at cell surfaces. Increasing evidence suggests the importance of CS and DS chains in several biological processes (for reviews see Refs. 13). Notably, CS chains regulate the development of the nervous system and play different roles as neuritogenic molecules (for reviews see Refs. 35) and as major inhibitors of axonal regeneration in the injured central nervous system (68). Such apparently contradictory functions are probably attributed to the structural heterogeneity of CS chains, as sulfation profiles change during development (9, 10). Structural features of CS involved in neuroregulatory events have been studied to a considerable extent by using oversulfated CS variants, CS-D and CS-E, from shark cartilage and squid cartilage, respectively (1117), although our knowledge of DS in the central nervous system remains rudimentary.
DS is a stereoisomeric variant of CS composed of repeating disaccharide units containing GlcUA and GalNAc, with varying proportions of IdoUA in place of GlcUA in a tissue-specific manner (18, 19). The characteristics of the GAG moieties of a CS-PG called DSD-1 (dermatan sulfate dependent-1)-PG/phosphacan, which was originally isolated from postnatal mouse brain (20), suggests that DS-type GAG chains are expressed in the brain as CS/DS hybrid chains with a larger proportion of GlcUA and a smaller proportion of IdoUA, in contrast to typical skin DS chains with a high content of IdoUA (19). We have shown that diverse oversulfated DS chains derived from various marine organisms promote the outgrowth of neurites in primary hippocampal neurons of the mouse, suggesting the involvement of DS-type structures, in addition to their sulfation profiles, in the neuritogenesis (2123). This notion was strongly supported by the demonstration of significant neuritogenic and growth factor binding activities of CS/DS hybrid chains isolated from embryonic pig brain, which contain a higher proportion of IdoUA than those prepared from adult pig brain (24, 25). Therefore, characteristic, functional CS/DS hybrid chains may be distributed in the brain parenchyma, where the neural network forms during development. However, the spatiotemporal distribution of such IdoUA-containing CS/DS hybrid structures in the brain remains largely unknown because of analytical difficulties. The structural variability of CS/DS chains is biosynthetically generated under the control of multiple sulfotransferases and glucuronyl C5 epimerase that converts GlcUA to IdoUA at the polymer level (for reviews see Refs. 18, 26, 27). 4-O-Sulfation of GalNAc residues is a high frequency modification of CS/DS, and such a sulfation has been postulated to be involved in the formation of IdoUA by C5-epimerization of GlcUA. Previously, we have demonstrated the substrate specificities of three CS/DS 4-O-sulfotransferases, dermatan 4-O-sulfotransferase-1 (D4ST-1) and chondroitin 4-O-sulfotransferases-1 and -2 (C4ST-1 and C4ST-2), toward partially desulfated DS (28). The results suggest a substantial contribution of D4ST-1 to the formation of IdoUA-rich regions consisting largely of a disaccharide iA unit (IdoUA-GalNAc(4S)) characteristic of DS, and the potential involvement of C4STs in the 4-O-sulfation of GalNAc residues next to IdoUA. In addition, a single uronyl 2-O-sulfotransferase (UST) catalyzes preferentially the 2-O-sulfation of IdoUA of iA units (29), forming another DS-specific iB unit IdoUA(2S)-GalNAc(4S), where 2S and 4S represent 2-O- and 4-O-sulfate groups, respectively. In view of their substrate preferences for DS precursor chains, the gene expression patterns of these sulfotransferases would provide clues for investigating the regional distribution pattern of IdoUA-containing CS/DS hybrid chains in tissues. Hence, we examined the gene expression of the four CS/DS sulfotransferases described above during postnatal development of the mouse brain by in situ hybridization to probe the distribution of such hybrid chains in the brain parenchyma. Furthermore, we demonstrated a good correlation between the gene expression profiles and the distribution pattern of IdoUA-containing CS/DS structures produced by the gene products based on an in situ analysis of the disaccharide composition of the CS/DS chains in brain sections.
MaterialsThe following sugars and enzymes were purchased from Seikagaku Corp. (Tokyo, Japan): five authentic unsaturated CS disaccharides, conventional chondroitinase ABC (EC 4.2.2.4 [EC] ) from Proteus vulgaris, and chondroitinase AC-I (EC 4.2.2.5 [EC] ) from Flavobacterium heparinum. The monoclonal anti-CS antibody 473HD (20) was provided by Andreas Faissner (Department of Cell Morphology and Molecular Neurobiology, Ruhr-University, Germany).
Cloning of Mouse cDNAs Encoding Sulfotransferases Involved in CS/DS BiosynthesiscDNAs of four mouse sulfotransferases (D4ST-1, C4ST-1, C4ST-2, and UST) were amplified from mouse heart Marathon-Ready cDNA (Clontech) by two-round PCRs using respective primer sets corresponding to the 5'- and 3'-noncoding regions. For a cDNA fragment ( In Situ HybridizationBrains were quickly removed from postnatal day (P) 7, P14, and P21 ddY mice and 7-week-old (W) male ddY mice and frozen in powdered dry ice. Consecutive brain sections were cut at a thickness of 16 µm with a cryostat (Leica Microsystems, Tokyo, Japan), thaw-mounted onto 3-aminopropyltriethoxysilane-precoated glass slides, and stored at 80 °C prior to use.
35S-Labeled riboprobes were transcribed using a MAXIscriptTM T7 kit (Ambion, Austin, TX) with 5'-
Quantitative Real Time RT-PCRTotal RNA was extracted from entire brains or cerebella of P7, P14, and P21 ddY mice and 7W male ddY mice using a QuickPrep total RNA extraction kit (Amersham Biosciences). The cDNA was synthesized from
Determination of the Disaccharide Composition of CS/DS Chains in the Brain Sections on Glass SlidesThe digestion of CS/DS chains in the brain sections on glass slides with CS/DS-degrading enzymes was carried out as described previously (31) with slight modifications. The tissue sections prepared as above were fixed with acetone/methanol (1:1, v/v) at room temperature for 3 min and dried. For the analysis of CS/DS chains in the cerebella, unnecessary portions of the brain sections were scratched off with a fine surgical knife under a dark field microscopic view. The photographs of the clipped tissue sections were scanned under a dark field microscope (SZX12; Olympus, Tokyo, Japan) equipped with a digital camera (HC-300Z/OL; Olympus) for calculating the area using morphological analysis software (Mac Scope; Mitani Corp., Tokyo, Japan). The sections were rehydrated in distilled water at room temperature for 10 min. Depending upon the relative size of each section, an appropriate volume (25150 µl) of an enzyme solution mixture containing chondroitinase ABC (25 mIU/ml) or AC-I (25 mIU/ml) in 50 mM Tris-HCl buffer, pH 7.3 (32), was applied on the sections. It should be noted that the enzymatic digestion with chondroitinase ABC was also carried out in the above-mentioned buffer instead of the conventional buffer (50 mM Tris-HCl buffer, pH 8.0, containing 60 mM sodium acetate) (32), based on the prior selection of an optimal buffer for digestion with chondroitinase ABC and subsequent efficient labeling with a fluorophore, 2-aminobenzamide (2AB).4 The sections were incubated in a moisture chamber at 37 °C for 2 h. The enzyme solutions were then collected, dried, and subjected to derivatization with 2AB as described previously (33). After the removal of excess 2AB reagent by paper chromatography, the resultant 2AB derivatives of the unsaturated disaccharides listed below were identified and quantified by anion-exchange HPLC on an amine-bound silica PA03 column (4.6 x 250 mm, YMC Co., Kyoto, Japan) with a linear gradient of NaH2PO4 from 16 to 530 mM over 60 min at a flow rate of 1 ml/min (33) or by gel filtration on a SuperdexTM Peptide HR10/30 column (Amersham Biosciences) equilibrated with 0.2 M NH4HCO3 containing 7% (v/v) 1-propanol as described previously (24): 4,5HexUA 13GalNAc ( Di-0S or O unit) derived from GlcUA-GalNAc (O unit); 4,5HexUA 13GalNAc(6S) ( Di-6S or C unit) from GlcUA-GalNAc(6S) (C unit) or IdoUA-GalNAc(6S) (iC unit); 4,5HexUA 13GalNAc(4S) ( Di-4S or A unit) from GlcUA-GalNAc(4S) (A unit) or IdoUA-GalNAc(4S) (iA unit); 4,5HexUA(2S) 13GalNAc(6S) ( Di-diSD or D unit) from GlcUA(2S)-GalNAc(6S) (D unit) or IdoUA(2S)-GalNAc(6S) (iD unit); 4,5HexUA(2S) 13GalNAc(4S) ( Di-diSB or B) from GlcUA(2S)-GalNAc(4S) (B unit) or IdoUA(2S)-GalNAc(4S) (iB unit); and 4,5HexUA 13Gal-NAc(4,6-O-disulfate) ( Di-diSE or E unit) from GlcUA-GalNAc(4S,6S) (E unit) or IdoUA-GalNAc(4S,6S) (iE unit) (3, 4).
Alternatively, a GAG fraction was prepared from brain sections by the conventional method (24, 34) with slight modifications. Several brain sections were directly homogenized with acetone, and the acetone-insoluble materials were collected by centrifugation. After drying, the CS/DS chain-containing precipitates were treated with 1 M NaBH4, 0.05 M NaOH at room temperature for 2 h to liberate O-linked saccharides including GAG chains from the core proteins. After neutralization with 1 M acetic acid and subsequent treatment with 5% (w/v) trichloroacetic acid, a GAG-containing fraction was recovered by ethanol precipitation. An aliquot of the resultant GAG fraction was used for the analysis of the disaccharide composition described above. Brain sections on glass slides were immunostained with the monoclonal anti-CS antibody 473HD, which has been originally reported to recognize the GAG moiety of a brain-derived CS-PG, DSD-1-PG/phosphacan, and has long been postulated to react with unique CS/DS hybrid structures (20), before and after treatment with the enzyme solution containing chondroitinase ABC to confirm the efficient removal of CS/DS chains from the sections.
Expression of CS/DS GalNAc 4-O-Sulfotransferases in the Mouse Brain during Postnatal DevelopmentDS-type GAG chains have been postulated to be formed from precursor chondroitin chains by C5-epimerization of GlcUA into IdoUA residues, accompanied by 4-O-sulfation of the neighboring GalNAc residues. In view of the in vitro substrate specificities of human sulfotransferases involved in the 4-O-sulfation of CS/DS (28, 35), mainly D4ST-1 has been considered to be involved in the formation of IdoUA in the biosynthesis of CS/DS hybrid chains (28, 35). Thus, to gain insights into the distribution of such IdoUA-containing CS/DS hybrid chains in the mouse brain during postnatal development, expression of the mouse counterparts of the three human family members of CS/DS GalNAc 4-O-sulfotransferases, D4ST-1, C4ST-1, and C4ST-2, was examined by in situ hybridization with their respective 35S-labeled antisense probes.
Fig. 1 shows autoradiograms of the sagittal sections from the brains of P7, P14, P21, and 7W mice. Distinct patterns of labeling were observed for C4ST-1 and C4ST-2 in widespread regions of the developing brain, including the olfactory bulb, caudate putamen, cerebral cortex, hippocampus, thalamus, midbrain, and cerebellum (Fig. 1, EL). In the negative control experiments with the respective 35S-labeled sense probes, essentially no label was observed in any region (data not shown), confirming the specific hybridization of the antisense probes. In contrast, the expression level of D4ST-1 was low compared with levels of C4STs. Interestingly, however, the transcript of D4ST-1 was exclusively expressed in the cerebellum throughout the postnatal developmental stages examined (Fig. 1, AD). Similar results were obtained in the autoradiograms of consecutive coronal sections of the brain, including the cerebellum (Fig. 2). Consistent with these findings, quantitative real time RT-PCR revealed that the expression level of D4ST-1 in the cerebellum was relatively higher than that in the whole brain and culminated at P14 during postnatal development (Fig. 3A), whereas C4ST-1 was expressed at a similar level in both the cerebellum and the whole brain at all stages examined (Fig. 3B), indicating its ubiquitous expression in the postnatal brain. These gene expression patterns suggest that IdoUA-containing CS/DS hybrid chains are relatively abundant in the cerebellum during postnatal brain development.
Quantification of CS/DS Chains in Brain Sections on Glass SlidesIn order to study the regional distribution pattern of IdoUA-containing CS/DS hybrid structures in the postnatal mouse brain, the disaccharide composition of the CS/DS chains was determined using the in situ digestion method in histological sections on glass slides with CS/DS-degrading enzymes (31), because this method has been established for rapid determination of the concentration of CS/DS chains in the targeted local area with a defined thickness on the tissue section. Because the DS-specific D4ST-1 was abundantly expressed in the cerebellum, the analysis was focused on the structural difference in CS/DS chains between the cerebellar region and the entire brain. For the analysis of the cerebellar CS/DS, brain sections on glass slides were processed to analyze the cerebellar region by removing the other parts with a small surgical knife. The enzyme solution containing chondroitinase ABC was mounted on the respective sections to digest the CS/DS chains directly on the slides. Chondroitinase ABC catalyzes the eliminative cleavage of almost all the galactosaminidic linkages in CS/DS chains (36, 37). Exhaustive treatment with chondroitinase ABC efficiently removed CS/DS chains from the sections, as confirmed by the elimination of the immunoreactivity toward anti-CS mAb 473HD in the sections (data not shown). The enzyme reaction mixture was recovered and derivatized with a fluorophore, 2AB. The 2AB derivatives of the CS/DS disaccharide components were subjected to anion-exchange HPLC, and their fluorescence intensity was monitored. Representative chromatograms obtained using enzyme digests of the whole brain sections and cerebellar sections are shown in Fig. 4. The unsaturated CS/DS disaccharides observed in the digests were identified by comparison with the elution positions of the authentic 2AB-labeled disaccharide standards. To verify the validity of the in situ method, the conventional method was also used, where CS/DS chains were first purified from the sections, then digested with chondroitinase ABC, and subjected to anion-exchange HPLC after 2AB-labeling (as described under "Experimental Procedures"). A similar chromatographic profile of the fluorescently labeled disaccharides was observed (data not shown), except that the recovery of total disaccharide obtained with the conventional method was 70% less than that obtained using the in situ method. Thus, the in situ method was more efficient for the highly sensitive detection and quantitative estimation of CS/DS disaccharides derived from the tissue sections. The lower recovery with the conventional method was assumed to be due to the low efficiency of the purification of minute amounts of the materials.
The data obtained from the direct digestion of CS/DS chains in the brain sections are summarized in Table 1. Accurate values for the nonsulfated disaccharide O( Di-0S) could not be obtained because of the methodological imperative of its loss during the step of purification to remove the excess reagents for 2AB derivatization and impurities derived from tissue sections. Nevertheless, the approximate proportion of O was roughly estimated for the CS/DS chains derived from tissue sections of whole brain and the cerebellum at P14 and 7W after the removal of excess reagents by paper chromatography before HPLC analysis. The results indicated that 5% of all the disaccharides were O in both samples and that the disaccharide composition of CS/DS chains, including O, was essentially unchanged. Therefore, O was not pursued in this study. In both the whole brain and cerebellar sections, the proportion of A increased gradually, whereas that of C decreased with development, which was consistent with the previously reported developmental change in the sulfation pattern of the CS chains from embryonic chick brain (10). The temporal change in composition in the cerebellar sections was more dynamic than that in the whole brain sections (Table 1), which may reflect the dramatic development of the cerebellar system after birth. Interestingly, a marked (2-fold) increase in the concentration of total CS/DS in the cerebellum was observed, whereas that in the entire brain was moderate (20%) (Table 1).
The proportions of disulfated disaccharide components, D, E, and B, in the CS/DS chains obtained from both the whole brain and cerebellar sections were relatively small throughout the postnatal development (Table 1). However, growing evidence suggests the biological significance of even such small proportions of disaccharide units in CS/DS chains (3). Therefore, the temporal change in their proportion was also examined. In the whole brain sections, the proportion of B and E showed a gradual increase and concomitant decrease with development, respectively, whereas that of D appeared unaltered. In contrast, dramatic changes in the proportion of the three disulfated disaccharide components in the cerebellar CS/DS chains were observed; the proportion of D and E decreased to 50 and 30%, respectively, whereas that of B increased as much as 10-fold with development. The marked sharp increase in the proportion of B in cerebellar CS/DS is especially noteworthy and may provide clues for understanding the distribution of IdoUA-containing CS/DS hybrid structures in the postnatal brain as described below.
A Significant Proportion of the IdoUA-containing Disaccharide Unit iA Exists in the Cerebellar CS/DS ChainsRecently, it was demonstrated that CS/DS chains isolated from a soluble PG fraction of embryonic pig brains contained a significantly higher proportion (89%) of iA than the corresponding fraction obtained from adult pig brains (24). Therefore, iA units were compared between whole brain and the cerebellum. Unsaturated disaccharide
Expression of D4ST-1 and UST Involved in the Biosynthesis of Disulfated Disaccharide iB Units in the Cerebellar CS/DS ChainsAs mentioned above, the proportion of B in the cerebellar CS/DS chains was dramatically increased by 10-fold from P7 to 7W, despite its relatively small increase ( 2-fold) in CS/DS chains derived from whole brain during the same time period. B is formed by chondroitinase digestion from a disulfated B unit (GlcUA(2S-)-GalNAc(4S)) and iB unit (IdoUA-(2S)-GalNAc(4S)). However, it should be noted that the B unit has never been reported in mammalian tissues, although it was recently detected for the first time in shark skin (23). Therefore, it is most likely that B was derived from iB rather than B units. Indeed, B was not produced by chondroitinase AC-I specific for CS. Because the iB unit is a characteristic component of typical DS chains, comparison of the proportion of iB in the total CS/DS disaccharides in a particular brain region is useful for a preliminary survey of the distribution of CS/DS hybrid structures. In the biosynthesis of DS chains containing the iB unit, it has been postulated that a biosynthetic intermediate (IdoUA-GalNAc(4S); iA unit) is first produced from a disaccharide unit (GlcUA-GalNAc; O unit) by the cooperative actions of C5 epimerase and D4ST-1 (28, 35, 38). UST catalyzes thereafter 2-O-sulfation of uronyl residues, particularly IdoUA residues in iA units in DS chains (29). As expected, in situ hybridization revealed that UST, as well as D4ST-1, was highly expressed in cerebellum during postnatal development (Fig. 5). Real time RT-PCR also revealed that the expression level of UST was relatively high in the cerebellum throughout development and culminated at P14 (Fig. 3C). Thus, the iA units embedded in cerebellar CS/DS chains may be efficiently sulfated by the action of UST, leading to the high production of the DS-specific iB unit in the postnatal cerebellum.
The expression levels of another two sulfotransferases, chondroitin 6-O-sulfotransferase-1 (C6ST-1) and GalNAc 4-sulfate 6-O-sulfotransferase (GalNAc4S-6ST), were also analyzed by real time RT-PCR. The former catalyzes the 6-O-sulfation of GalNAc residues and contributes substantially to the formation of the C and D units (39, 40), whereas the latter catalyzes the 6-O-sulfation of GalNAc(4S) in A units and is responsible for the formation of the E unit (41). In contrast to D4ST-1 and UST, although the expression levels of C6ST-1 and GalNAc4S 6ST in the cerebellum were higher than those in the whole brain, they gradually decreased with development (Fig. 3, D and E). Their temporal expression profiles in the cerebellum may support the gradual decrease in the proportions of
Distribution of IdoUA Residues along Mouse Brain CS/DS ChainsTo further characterize the structural properties of the IdoUA-containing CS/DS hybrid chains, the distribution of IdoUA residues along the chains was compared between CS/DS chains derived from the entire brain and cerebellum at 7W. Each section was treated with chondroitinase AC-I, and the digest was labeled with 2AB and analyzed by gel filtration. As shown in Fig. 6, fluorescent peaks derived from each digest were detected at positions corresponding to tetra-, hexa-, and octasaccharides, in addition to monosulfated and disulfated disaccharides, which are designated mono-S and di-S fractions, respectively. Considering the substrate specificity of chondroitinase AC-I (36, 37), the oligosaccharides resistant to chondroitinase AC-I should be derived from sequences containing iA, iB, iC, iD, iE, and/or D units (GlcUA(2S)-GalNAc(6S)). Each broad peak close to V0 in both chromatograms (Fig. 6) was composed of unidentified impurities, as judged by the resistance to treatment with chondroitinase ABC followed by 2AB labeling, which gave no fluorescent peaks corresponding to disaccharides (data not shown). In addition, anion-exchange HPLC analysis showed that the di-S fraction contained a small proportion of
In this study, the characteristic spatiotemporal distribution of IdoUA-containing CS/DS hybrid chains in the postnatal mouse brain was demonstrated by in situ hybridization for sulfotransferases involved in the biosynthesis of DS and by chemical in situ analysis of CS/DS chains of the brain sections. Both approaches showed that IdoUA-containing CS/DS hybrid structures are more concentrated in the cerebellum when compared with whole brain, providing insight into the important biological functions of IdoUA-containing CS/DS hybrid chains during postnatal cerebellar development as discussed below. Typical mammalian DS chains are characterized by distinct iA and iB disaccharide units as exemplified by DS in skin (42). 4-O-Sulfation of GalNAc is postulated to be responsible for the prior formation of IdoUA by C5-epimerization of GlcUA (38), which is an initial step in the biosynthesis of DS. Our previous study revealed that the 4-O-sulfation is catalyzed by members of the CS/DS 4-O-sulfotransferase family as follows: D4ST-1, C4ST-1, and C4ST-2 (28). Their substrate preferences suggest that D4ST-1 contributes substantially to the formation of IdoUA in vivo, resulting in production of the iA unit along the precursor chains. In addition, Kobayashi et al. (29) has reported that UST catalyzes efficiently the 2-O-sulfation of IdoUA residues of iA units, forming iB units. The preferential expression of D4ST-1 and UST in the developing cerebellum (Figs. 1, 2, 3 and 5) was positively correlated with the relatively larger proportions of iA and iB units along the cerebellar CS/DS chains compared with the chains from whole brain (Table 1). These findings verify the reliability and potential applicability of these gene expression profiles for probing the presence of IdoUA-containing CS/DS hybrid chains. In contrast, C4ST-1 and C4ST-2 showed a widespread expression in the postnatal brain (Figs. 1, 2, 3). Although their expression cannot be used for surveying the distribution of IdoUA-containing DS-type structures, they might also be partially involved in the formation of IdoUA in CS/DS chains in the postnatal brain. It has been reported that the sulfation profiles of CS chains change markedly with embryonic development in the chick brain (10). This change, which is characterized by an increase in 4-O-sulfation and a decrease in 6-O-sulfation, was also observed in the postnatal mouse brain-derived CS/DS chains, especially in the cerebellar region (Table 1), where neural development proceeds dramatically during the postnatal period. In addition, temporal change in the proportions of iA and iB units was also observed. Despite the up-regulation of D4ST-1 expression in the developing cerebellum, the postnatal maturation of the cerebellum resulted in a decrease in the proportion of iA among A and iA from 11 (at P7 and P14) to 7% (at P21 and 7W) (Table 2). This apparent discrepancy may be explained by a significant increase in the iB units (Table 1), which are produced by UST efficiently utilizing a fraction of the preformed iA units as intermediates. In view of recent reports about the contribution of IdoUA-containing disaccharides in addition to the sulfation profiles to the neuritogenic activity of embryonic pig brain-derived CS/DS (24, 25), the dynamic changes in disaccharide composition, including iA and iB units, in the cerebellar CS/DS chains appear to reflect the neural development and/or maturation of the cerebellum.
Increasing evidence shows that most neuritogenic CS/DS chains possess the ability to bind growth factors (3, 20, 2224, 43), suggesting that these neuroregulatory activities are exerted at least in part through signal transductions mediated by several growth factors. Most interestingly, Bao et al. (25) have reported that embryonic pig brain-derived CS/DS, which contains a significant proportion of IdoUA residues, supports in part pleiotrophin (PTN)-mediated neuritogenesis of primary hippocampal neurons by recruiting endogenous PTN produced by glial cells. PTN, a heparin-binding growth factor, binds not only to heparan sulfate (HS)-PGs but also to CS-PGs through their CS moieties. Typically, such CS-PGs include a cell membranetethered receptor-type tyrosine phosphatase, PTP Interestingly, CS-D from shark cartilage containing D units and an oversulfated DS preparation derived from ascidian Styela plicata, which is characterized by a prominence of the disaccharide unit iB, promote the outgrowth of neurites in rodent hippocampal neurons in vitro, resulting in the induction of multiple shorter neurites. In contrast, they do not produce an axonic longer neurite, which is typically observed in neurons cultured on defined substrates such as other marine organism-derived CS/DS hybrid chains containing mainly E/iE units (13, 21). The apparently similar morphogenetic potential of D and iB units is consistent with the finding that the cerebellar CS/DS chains with significant proportions of iB, in addition to D, function at least in part in the neuritogenesis of cerebellar neurons during postnatal development. In support of this notion, we recently observed that DS preparation from ascidian S. plicata promoted neurite outgrowth not only of hippocampal neurons (21) but also of cerebellar neurons when used as a substrate for dissociated culture.5 However, several studies have suggested that CS/DS chains, which can promote neurite outgrowth of a particular cell type, do not always guarantee neuritogenesis of another. For example, CS-E, which is characterized by a predominance of the E unit, promotes neurite outgrowth of embryonic mouse hippocampal neurons in vitro (13, 21), although it is potently inhibitory toward dorsal root ganglion explants from chick embryos (48). DSD-1-PG has been also reported to show similar opposing effects on neuritogenesis dependent on neuronal lineages (49). In view of these findings, further investigation is needed for clarification of the biological importance of CS/DS hybrid chains containing iA and/or iB units in the primary cerebellar neurons.
Notably, recent studies demonstrated that oligosaccharide structures rich in iA units present in DS chains are capable of promoting the signal transduction mediated by basic fibroblast growth factor (bFGF) (50). bFGF has various neuroregulatory functions influencing neuronal proliferation, differentiation, and neuroprotection (5153). Although it is well established that the bFGF-mediated events are supported by HS chains as co-receptors (54), the CS/DS hybrid chains expressed in the postnatal cerebellum may also support bFGF-mediated neurotrophic effects on cerebellar neurons such as Purkinje cells and granular cells.
Gel filtration analysis of the enzymatic digest of the brain sections obtained with chondroitinase AC-I revealed that the clusters consisting of IdoUA-containing iA and iB units, and GlcUA-containing rare D units were distributed Interestingly, the abundant distribution of IdoUA-containing CS/DS hybrid chains in the postnatal cerebellum is probably correlated with the epitope of the monoclonal antibody (mAb) 473HD (12). 473HD has long been postulated to react with CS/DS hybrid structures, and its epitope was preferentially distributed in the cerebellum among adult brain subregions examined (12, 20). Several studies have shown that the 473HD epitope was also distributed in the embryonic brain (49, 57), where dynamic neurogenesis occurs before onset of cerebellar formation. 473HD can neutralize the neurite outgrowth-promoting activities of CS-D and embryonic pig brain CS/DS (13, 25). Most recently, Ito et al. (56) showed that the 473HD epitope might be associated with structure(s), which include IdoUA-containing units, in addition to AD and/or DA tetrasaccharide sequences. These findings may imply that functional IdoUA-containing CS/DS hybrid chains are prominent in the brain subregions where the drastic formation of neural network is observed. Therefore, application of the systematic analyses performed in the present study to the embryonic central nervous system will facilitate a more comprehensive understanding of the biological functions of IdoUA-containing CS/DS hybrid chains in the developing central nervous system, including a hippocampus, whose neurons extend neurites in response to the stimulation with brain CS/DS chains from the embryonic stage (24, 25).
* This work was supported in part by the Science Research Promotion Fund from the Japan Private School Promotion Foundation, and Grant-in-aid for Encouragement of Young Scientists 16790068 (to T. M.), Exploratory Research 15659021 (to K. S.), The Human Frontier Science Program, and Scientific Research-B 16390026 (to K. S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 Both authors contributed equally to this work. 2 Supported by the Core Research for Evolutional Science and Technology, Japan Science and Technology Agency. To whom correspondence should be addressed: Faculty of Advanced Life Science, Hokkaido University, Frontier Research Center for Post-Genomic Science and Technology, Nishi 11-choume, Kita 21-jo, Kita-ku, Sapporo 001-0021, Japan. Tel.: 81-11-706-9054; Fax: 81-11-706-9056; E-mail: k-sugar{at}sci.hokudai.ac.jp.
3 The abbreviations used are: CS, chondroitin sulfate; DS, dermatan sulfate; GAG, glycosaminoglycan; PG, proteoglycan; D4ST, dermatan 4-O-sulfotransferase; C4ST, chondroitin 4-O-sulfotransferase; UST, uronyl 2-O-sulfotransferase;
4 C. Mitsunaga, T. Mikami, and K. Sugahara, unpublished results.
5 T. Mikami and K. Sugahara, unpublished results.
We thank Kana Ogura (Kobe Pharmaceutical University) for technical assistance and Dr. Ichiro Koshiishi (Nihon Pharmaceutical University) for technical advice regarding the in situ chemical disaccharide analysis.
This article has been cited by other articles:
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||